UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Sun Exposure across the Life Course Significantly Modulates Early Multiple Sclerosis Clinical Course

Frontiers in neurology, 2018-02, Vol.9, p.16

2018

Volltextzugriff (PDF)

A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis

PloS one, 2010-12, Vol.5 (12), p.e14176-e14176

2010

Volltextzugriff (PDF)

Onset Symptoms, Tobacco Smoking, and Progressive-Onset Phenotype Are Associated With a Delayed Onset of Multiple Sclerosis, and Marijuana Use With an Earlier Onset

Frontiers in neurology, 2018-06, Vol.9, p.418-418

2018

Volltextzugriff (PDF)

010 Real-world experience with ocrelizumab in the MSBase registry – Australian RRMS cohort

BMJ neurology open, 2021-08, Vol.3 (Suppl 1), p.A4-A5

2021

Volltextzugriff (PDF)

Favourable Outcome in a 33-Year-Old Female with Acute Haemorrhagic Leukoencephalitis

Case reports in neurology, 2017-01, Vol.9 (1), p.106-113

2017

Volltextzugriff (PDF)

Genetically determined serum serine level has a novel causal effect on multiple sclerosis risk and predicts disability progression

Journal of neurology, neurosurgery and psychiatry, 2023-07, Vol.94 (7), p.526

2023

Volltextzugriff (PDF)

High Prudent diet factor score predicts lower relapse hazard in early multiple sclerosis

Multiple sclerosis, 2021-06, Vol.27 (7), p.1112-1124

2021

Volltextzugriff (PDF)

Novel plasma and brain proteins that are implicated in multiple sclerosis

Brain (London, England : 1878), 2023-06, Vol.146 (6), p.2464-2475

2023

Volltextzugriff (PDF)

Lipid-related genetic polymorphisms significantly modulate the association between lipids and disability progression in multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2019-06, Vol.90 (6), p.636

2019

Volltextzugriff (PDF)

MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood

PloS one, 2010-08, Vol.5 (8), p.e12132-e12132

2010

Volltextzugriff (PDF)

Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20

Nature genetics, 2009-07, Vol.41 (7), p.824-828

2009

Volltextzugriff (PDF)

Anxiety, depression and fatigue at 5-year review following CNS demyelination

Acta neurologica Scandinavica, 2016-12, Vol.134 (6), p.403-413

2016

Volltextzugriff (PDF)

Common genetic variation within miR-146a predicts disease onset and relapse in multiple sclerosis

Neurological sciences, 2018-02, Vol.39 (2), p.297-304

2018

Volltextzugriff (PDF)

Estimation of annual probabilities of changing disability levels in Australians with relapsing-remitting multiple sclerosis

Multiple sclerosis, 2019-11, Vol.25 (13), p.1800-1808

2019

Volltextzugriff (PDF)

Defining secondary progressive multiple sclerosis

Brain (London, England : 1878), 2016-09, Vol.139 (Pt 9), p.2395-2405

2016

Volltextzugriff (PDF)

Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility

PloS one, 2011-02, Vol.6 (2), p.e16964-e16964

2011

Volltextzugriff (PDF)

Mr. Machiavelli's Choice for Treatment of MOG Antibody Disease: Do the benefits of long-term corticosteroids justify the means?

Multiple sclerosis and related disorders, 2024-09, Vol.89, p.105794, Article 105794

2024

Volltextzugriff (PDF)

Open access publishing and the future of scientific communication

Multiple sclerosis and related disorders, 2024-06, Vol.86, p.105625-105625, Article 105625

2024

Volltextzugriff (PDF)

Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients

PloS one, 2010-04, Vol.5 (4), p.e10003-e10003

2010

Volltextzugriff (PDF)

An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event

Journal of neurology, neurosurgery and psychiatry, 2017-05, Vol.88 (5), p.395

2017

Volltextzugriff (PDF)

Developing a clinical–environmental–genotypic prognostic index for relapsing-onset multiple sclerosis and clinically isolated syndrome

Brain communications, 2021, Vol.3 (4), p.fcab288-fcab288

2021

Volltextzugriff (PDF)

Migraine and multiple sclerosis: The final answer?

Multiple sclerosis and related disorders, 2023-06, Vol.74, p.104769-104769, Article 104769

2023

Volltextzugriff (PDF)

The biological rabbit hole: Only for the blind

Multiple sclerosis and related disorders, 2022-11, Vol.67, p.104256-104256, Article 104256

2022

Volltextzugriff (PDF)

Cancer risk and mortality in multiple sclerosis: The need for vigilance

Multiple sclerosis and related disorders, 2023-01, Vol.69, p.104519-104519, Article 104519

2023

Volltextzugriff (PDF)

EBV as the “gluten of MS” hypothesis provides a rationale for trialing antiviral therapies

Multiple sclerosis and related disorders, 2022-08, Vol.64, p.104007-104007, Article 104007

2022

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(57)
Berichte
(1)

Sprache

Englisch
(58)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Sun Exposure across the Life Course Significantly Modulates Early Multiple Sclerosis Clinical Course

A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis

Onset Symptoms, Tobacco Smoking, and Progressive-Onset Phenotype Are Associated With a Delayed Onset of Multiple Sclerosis, and Marijuana Use With an Earlier Onset

010 Real-world experience with ocrelizumab in the MSBase registry – Australian RRMS cohort

Favourable Outcome in a 33-Year-Old Female with Acute Haemorrhagic Leukoencephalitis

Genetically determined serum serine level has a novel causal effect on multiple sclerosis risk and predicts disability progression

High Prudent diet factor score predicts lower relapse hazard in early multiple sclerosis

Novel plasma and brain proteins that are implicated in multiple sclerosis

Lipid-related genetic polymorphisms significantly modulate the association between lipids and disability progression in multiple sclerosis

MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood

Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20

Anxiety, depression and fatigue at 5-year review following CNS demyelination

Common genetic variation within miR-146a predicts disease onset and relapse in multiple sclerosis

Estimation of annual probabilities of changing disability levels in Australians with relapsing-remitting multiple sclerosis

Defining secondary progressive multiple sclerosis

Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility

Mr. Machiavelli's Choice for Treatment of MOG Antibody Disease: Do the benefits of long-term corticosteroids justify the means?

Open access publishing and the future of scientific communication

Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients

An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event

Developing a clinical–environmental–genotypic prognostic index for relapsing-onset multiple sclerosis and clinically isolated syndrome

Migraine and multiple sclerosis: The final answer?

The biological rabbit hole: Only for the blind

Cancer risk and mortality in multiple sclerosis: The need for vigilance

EBV as the “gluten of MS” hypothesis provides a rationale for trialing antiviral therapies

Suchergebnisse filtern